Back

Preclinical study and evaluation of S016, a novel oral small-molecule PCSK9 inhibitor

30 August 2026 (10:15 - 10:45)
Organised by: Logo
Congress Presentation Part of: New advancements in targeting atherogenic lipoproteins Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Guodong Cen

Sichuan University, Chengdu - Sichuan (China)

3 More presentations in this session

Presentation thumbnail
Long-term outcomes of beta-blockers in post-MI patients with mildly reduced or preserved left ventricular ejection fraction: a systematic review and meta-analysis
Doctor K. Hosseini (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Inclisiran in combination with statin therapy achieves profound LDL-C and lipoprotein(a) reduction without acute cardiovascular events in high-risk patients with familial hypercholesterolemia
Doctor K. Dyankov (Sofia, BG)
Abstract Slides Video
Presentation thumbnail
Efficacy of PCSK9 inhibitors in patients with peripheral artery disease: insights from the AT-TARGET-IT Registry
Doctor M. Di Santo (Naples, IT)
Abstract Slides Video

Access the full session

Session thumbnail
New advancements in targeting atherogenic lipoproteins

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Oral PCSK9 inhibitors
30 August 2026
thumbnail
Congress Presentation
PCSK9i and atherosclerotic plaque regression assessed by coronary computed tomography angiography
31 August 2026
thumbnail
Congress Presentation
Safety, tolerability, pharmacokinetics and pharmacodynamics of HRS-1301, an oral PCSK9 inhibitor, in healthy participants: a first-in-human, randomized, double-blind, placebo-controlled phaseⅠtrial
28 August 2026
thumbnail
Congress Presentation
Identification of potent small-molecule PCSK9 inhibitors based on quantitative structure-activity relationship, pharmacophore modeling, and molecular docking procedure.
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources